AgomAb Therapeutics NV · NASDAQ:AGMB

Epstein David R bought 14,980 AgomAb Therapeutics NV shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 16, 2026

On Nov 13, 2026, Epstein David R (Director) bought 14,980 AgomAb Therapeutics NV shares at an average US$5.92 for US$88,679, leaving 54,980 shares. Filed Nov 16, 2026 (Form 4).

Bought
14,980 shares
Price
US$5.92 average (US$5.75 to US$6.02)
Value
US$88,679
Holding after
54,980 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common sharesBuy5,000US$5.9945,000Direct
Nov 13, 2026Common sharesBuy20US$6.0045,020Direct
Nov 13, 2026Common sharesBuy5,000US$5.7550,020Direct
Nov 13, 2026Common sharesBuy4,960US$6.0254,980Direct

Source

Download original · View original at SEC

Related